作为有前途的抗癌药物,二十年来对氧沙醇衍生物的概述
Mo'men Salem1, Khaled El-Adl2,3, Ahmed El-Morsy4,5
1Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Sinai University-Arish branch Arish Egypt.
RSC advances
|September 12, 2025
概括
奥克萨迪亚醇衍生物通过抑制瘤生长,显示出显著的抗癌特性. 本次审查强调了它们在药物开发中作为抗瘤剂的潜力.
科学领域:
- 药用化学 医学化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 癌症是一个主要的全球健康挑战,其特点是不受控制的细胞增殖.
- 异环化合物,特别是氧沙醇,对于开发新的化疗药物至关重要.
- 奥克萨迪亚的-氧异环核心因其强大的抗癌活性而闻名.
研究的目的:
- 审查1,3,4-氧化和1,2,4-氧化衍生物的抗癌性质.
- 探索它们在开发新型抗瘤剂中的潜在应用.
- 总结过去二十年来对氧沙衍生物的研究.
主要方法:
- 过去20年来科学研究的文献综述.
- 对研究的分析,重点是氧沙衍生物作为抗癌剂.
- 检查作用机制,包括酶抑制.
主要成果:
- 奥克萨迪亚醇衍生物具有显著的抗癌特性.
- 这些化合物通过抑制参与瘤进展的关键酶和生长因子来表现出潜力.
- 各种衍生品已被证明是有效的抗瘤剂.
结论:
- 1,3,4-氧化和1,2,4-氧化的支架对抗癌药物发现有希望.
- 对牛二醇衍生物的进一步研究可能会导致针对癌症的新疗法策略.
- 氧基亚醇代表了一类有价值的抗癌化合物.
更多相关视频
09:20Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
Published on: June 26, 2018
8.8K
07:40A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
Published on: May 27, 2021
4.5K
相关概念视频
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Inhibition of Cdk Activity
5.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.6K
Electron Transport Chain: Complex I and II
18.5K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
18.5K
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
817
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
817
